About this trial
Impaired inhibitory response manifests clinically as increased impulsivity, which leads to poorer affective, cognitive, social, and occupational functioning. Neuropsychiatric disorders prevalent among Veterans, such as Attention Deficit/Hyperactivity Disorder (ADHD), are associated with poor inhibitory control. The mainstay of clinical treatment for ADHD is psychostimulants, yet these medications have significant risks, including dependence and numerous side effects. Thus, novel and non-pharmacological therapeutic strategies are needed. Intermittent Theta Burst Stimulation, a newer form of transcranial magnetic stimulation, has emerged as a promising tool for modulating inhibitory neuronal circuits. This research proposal will investigate the feasibility and acceptability of iTBS on inhibitory control and impulsivity through a randomized controlled trial to inform clinical observations. The long-term goal is to improve impulsivity, social and occupational functioning, and enhance the quality of life for Veterans.
Eligibility criteria
Qualifiers
Diagnosis of ADHD predominantly hyperactive-impulsive or combined, as outlined in the DSM-5-TR criteria
Maintenance of clinical symptoms despite receiving stable treatment for a minimum of 6 weeks before the study procedures
Capability to comprehend and provide informed consent
For safety reasons, participants must meet established screening criteria to ensure safety during Magnetic Resonance Imaging (MRI) scans
Disqualifiers
Primary psychotic disorders, bipolar I disorder, ongoing severe substance use disorders, or active suicidality
Non-MRI safe cardiac pacemakers, implanted devices, or metallic implants at the upper thoracic spine level or higher
pregnancy
lactation
Trial design
Treatments tested in this trial
- Intermittent Theta-Burst Stimulation
- Sham Stimulation